Patients with borderline resectable pancreatic cancer are different from those with resectable ... For patients who are deemed unresectable, consideration should be given to definitive chemoradiation ...

Chemoradiation is considered a reasonable treatment option for patients with locally advanced, unresectable pancreatic cancer. The chemotherapy agents 5-fluorouracil, gemcitabine, capecitabine and ...

Symptoms of pancreatic cancer include ... “If it’s thought to be resectable, patients will have up-front Chemotherapy ...

multimodality therapy offers patients with unresectable colorectal cancer outcomes comparable to those with similarly staged, resectable tumors.

Opens in a new tab or window SAN FRANCISCO -- Three-fourths of patients with unresectable gastroesophageal cancer converted to resectable and had clear margins after treatment with a ...

Borderline-resectable pancreatic cancer (BRPC) accounts for nearly 20% of all pancreatic cancer cases diagnosed in the U.S. These tumors are often attached to nearby arteries or veins, making surgery ...

including safety and feasibility studies treating patients with pancreatic cancer, a combination study with pembrolizumab in patients with recurrent unresectable or metastatic HNSCC, and other ...

The company stated that it has dosed the first patient with JNJ-1900 in the phase II CONVERGE study to treat patients with Stage 3 unresectable ... advanced pancreatic cancer or borderline ...

The Gastrointestinal Tumor Study Group study and the Mayo Clinic study helped define chemoradiation with 5FU as the standard of care in locally advanced pancreatic cancer. Currently, typical ...